BMY vs ONTO · P/E 17, rev $24.46B vs P/E 23, rev $343.1M
Bristol-Myers Squibb Company (BMY) versus Onto Innovation Inc (ONTO) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Onto Innovation Inc (ONTO) is a semiconductor equipment & materials company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported ONTO revenue for 2026-06-30 was $343.1M. Net income was $60.1M. Revenue was up 17.5% from 2026-03-31 to 2026-06-30. ONTO currently screens at market cap $4.93B and trailing P/E 22.8.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. ONTO currently screens at market cap $4.93B and trailing P/E 22.8.
Not investment advice. Open the BMY and ONTO stock pages for the full models.
Not investment advice.